ReP USP - Resultado da busca

Artigo de periodico
Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component (2024)
Mendoza, Tânia Regina Tozetto ; Correa, Maria Cássia Jacintho Mendes ; Linhares, Iara Moreno; Raymundi, Vanessa de Cassia; Paiao, Heuder Gustavo de Oliveira; Barbosa, Erick Matheus Garcia; Luna-Muschi, Alessandra; Honorato, Layla; Correa, Giovanna Francisco; Costa, Sílvia Figueiredo
Source: Scientific reports. Unidade: FM
Subjects: COVID-19, EXPRESSÃO GÊNICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDOZA, Tânia Regina Tozetto et al. Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component. Scientific reports, v. 13, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56105. Acesso em: 07 nov. 2024.
APA
Mendoza, T. R. T., Correa, M. C. J. M., Linhares, I. M., Raymundi, V. de C., Paiao, H. G. de O., Barbosa, E. M. G., et al. (2024). Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component. Scientific reports, 13( 1). doi:10.1038/s41598-023-38095-9
NLM
Mendoza TRT, Correa MCJM, Linhares IM, Raymundi V de C, Paiao HG de O, Barbosa EMG, Luna-Muschi A, Honorato L, Correa GF, Costa SF. Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component [Internet]. Scientific reports. 2024 ; 13( 1):[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56105
Vancouver
Mendoza TRT, Correa MCJM, Linhares IM, Raymundi V de C, Paiao HG de O, Barbosa EMG, Luna-Muschi A, Honorato L, Correa GF, Costa SF. Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component [Internet]. Scientific reports. 2024 ; 13( 1):[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56105
Artigo de periodico
Apolipoprotein E 62 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study (2023)
Paradela, Regina Silva; Farias-Itao, Daniela Souza; Leite, Renata E. P; Pasqualucci, Carlos A ; Grinberg, Lea Tenenholz ; Naslavsky, Michel Satya; Zatz, Mayana; Nitrini, Ricardo ; Jacob Filho, Wilson ; Suemoto, Claudia Kimie
Source: Journal of stroke & cerebrovascular diseases. Unidades: SVOC, FM
Subjects: TRANSPORTE DE LIPÍDEOS, PROTEÍNAS DE TRANSPORTE, POLIMORFISMO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARADELA, Regina Silva et al. Apolipoprotein E 62 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study. Journal of stroke & cerebrovascular diseases, v. 32, n. 9, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56188. Acesso em: 07 nov. 2024.
APA
Paradela, R. S., Farias-Itao, D. S., Leite, R. E. P., Pasqualucci, C. A., Grinberg, L. T., Naslavsky, M. S., et al. (2023). Apolipoprotein E 62 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study. Journal of stroke & cerebrovascular diseases, 32( 9). doi:10.1016/j.jstrokecerebrovasdis.2023.107229
NLM
Paradela RS, Farias-Itao DS, Leite REP, Pasqualucci CA, Grinberg LT, Naslavsky MS, Zatz M, Nitrini R, Jacob Filho W, Suemoto CK. Apolipoprotein E 62 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study [Internet]. Journal of stroke & cerebrovascular diseases. 2023 ; 32( 9):[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56188
Vancouver
Paradela RS, Farias-Itao DS, Leite REP, Pasqualucci CA, Grinberg LT, Naslavsky MS, Zatz M, Nitrini R, Jacob Filho W, Suemoto CK. Apolipoprotein E 62 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study [Internet]. Journal of stroke & cerebrovascular diseases. 2023 ; 32( 9):[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56188
Artigo de periodico
Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy (2022)
Silva, Maria Cláudia da; Fuzo, Carlos Alessandro ; Paiva, Isadora Marques ; Bibo, Naira Lopes; Oliveira, Maykon Tavares de; Soares, Hellen Anastácia da Silva; Chevillard, Christophe; Kalil Filho, Jorge Elias ; Cunha Neto, Edecio ; Cunha, Thiago Mattar ; Silva, João Santana da
Source: Immunobiology. Unidades: FM, FMRP, FCFRP
Subjects: MUTAÇÃO, DOENÇA DE CHAGAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Maria Cláudia da et al. Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy. Immunobiology, v. 227, n. 5, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.imbio.2022.152242. Acesso em: 07 nov. 2024.
APA
Silva, M. C. da, Fuzo, C. A., Paiva, I. M., Bibo, N. L., Oliveira, M. T. de, Soares, H. A. da S., et al. (2022). Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy. Immunobiology, 227( 5), 1-7. doi:10.1016/j.imbio.2022.152242
NLM
Silva MC da, Fuzo CA, Paiva IM, Bibo NL, Oliveira MT de, Soares HA da S, Chevillard C, Kalil Filho JE, Cunha Neto E, Cunha TM, Silva JS da. Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy [Internet]. Immunobiology. 2022 ; 227( 5): 1-7.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.imbio.2022.152242
Vancouver
Silva MC da, Fuzo CA, Paiva IM, Bibo NL, Oliveira MT de, Soares HA da S, Chevillard C, Kalil Filho JE, Cunha Neto E, Cunha TM, Silva JS da. Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy [Internet]. Immunobiology. 2022 ; 227( 5): 1-7.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.imbio.2022.152242
Artigo de periodico
Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline (2019)
Tomaz, Paulo Roberto Xavier; Kajita, Mariana Soares; Santos, Juliana Rocha; Scholz, Jaqueline; Abe, Tania Ogawa; Gaya, Patricia Viviane; Krieger, José Eduardo ; Pereira, Alexandre Costa; Santos, Paulo Caleb Junior Lima
Source: European journal of clinical pharmacology. Unidade: FM
Subjects: POLIMORFISMO, FÁRMACOS (SISTEMA NERVOSO PERIFÉRICO), TABAGISMO, CITOCROMO P-450, GENÓTIPOS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZ, Paulo Roberto Xavier et al. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline. European journal of clinical pharmacology, v. 75, n. 11, p. 1541-1545, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00228-019-02731-z. Acesso em: 07 nov. 2024.
APA
Tomaz, P. R. X., Kajita, M. S., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., et al. (2019). Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline. European journal of clinical pharmacology, 75( 11), 1541-1545. doi:10.1007/s00228-019-02731-z
NLM
Tomaz PRX, Kajita MS, Santos JR, Scholz J, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PCJL. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline [Internet]. European journal of clinical pharmacology. 2019 ; 75( 11): 1541-1545.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00228-019-02731-z
Vancouver
Tomaz PRX, Kajita MS, Santos JR, Scholz J, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PCJL. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline [Internet]. European journal of clinical pharmacology. 2019 ; 75( 11): 1541-1545.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00228-019-02731-z
Artigo de periodico
Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C (2015)
Siqueira, Erika Rabelo Forte de; Pereira, Luciano Beltrao; Stefano, Jose Tadeu; Patente, Thiago; Cavaleiro, Ana Mercedes; Vasconcelos, Luydson Richardson Silva; Carmo, Rodrigo Feliciano; Pereira, Leila Maria Moreira Beltrao; Carrilho, Flair Jose; Corrêa-Giannella, Maria Lucia; Oliveira, Claudia P.
Source: European Journal of Medical Research. Unidade: FM
Subjects: HEPATIE C, POLIMORFISMO, SÍNDROME X METABÓLICA, HEPATITE CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIQUEIRA, Erika Rabelo Forte de et al. Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C. European Journal of Medical Research, v. 20, n. 45, p. 6 (online), 2015Tradução . . Disponível em: http://www.eurjmedres.com/content/pdf/s40001-015-0136-2.pdf. Acesso em: 07 nov. 2024.
APA
Siqueira, E. R. F. de, Pereira, L. B., Stefano, J. T., Patente, T., Cavaleiro, A. M., Vasconcelos, L. R. S., et al. (2015). Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C. European Journal of Medical Research, 20( 45), 6 (online). doi:10.1186/s40001-015-0136-2
NLM
Siqueira ERF de, Pereira LB, Stefano JT, Patente T, Cavaleiro AM, Vasconcelos LRS, Carmo RF, Pereira LMMB, Carrilho FJ, Corrêa-Giannella ML, Oliveira CP. Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C [Internet]. European Journal of Medical Research. 2015 ; 20( 45): 6 (online).[citado 2024 nov. 07 ] Available from: http://www.eurjmedres.com/content/pdf/s40001-015-0136-2.pdf
Vancouver
Siqueira ERF de, Pereira LB, Stefano JT, Patente T, Cavaleiro AM, Vasconcelos LRS, Carmo RF, Pereira LMMB, Carrilho FJ, Corrêa-Giannella ML, Oliveira CP. Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C [Internet]. European Journal of Medical Research. 2015 ; 20( 45): 6 (online).[citado 2024 nov. 07 ] Available from: http://www.eurjmedres.com/content/pdf/s40001-015-0136-2.pdf
Artigo de periodico
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy (2015)
Tomaz, Paulo Roberto Xavier; Santos, Juliana Rocha; Issa, Jaqueline Scholz; Abe, Tânia Ogawa; Gaya, Patrícia Viviane; Krieger, José Eduardo; Pereira, Alexandre Costa; Santos, Paulo Caleb Júnior Lima
Source: European Journal of Clinical Pharmacology. Unidade: FM
Subjects: TABAGISMO, POLIMORFISMO, EXPRESSÃO GÊNICA, FARMACOGENÉTICA, PROMOÇÃO DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZ, Paulo Roberto Xavier et al. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. European Journal of Clinical Pharmacology, v. 71, n. 9, p. 1067-1073, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs00228-015-1896-x. Acesso em: 07 nov. 2024.
APA
Tomaz, P. R. X., Santos, J. R., Issa, J. S., Abe, T. O., Gaya, P. V., Krieger, J. E., et al. (2015). CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. European Journal of Clinical Pharmacology, 71( 9), 1067-1073. doi:10.1007/s00228-015-1896-x
NLM
Tomaz PRX, Santos JR, Issa JS, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PCJL. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy [Internet]. European Journal of Clinical Pharmacology. 2015 ; 71( 9): 1067-1073.[citado 2024 nov. 07 ] Available from: http://link.springer.com/article/10.1007%2Fs00228-015-1896-x
Vancouver
Tomaz PRX, Santos JR, Issa JS, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PCJL. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy [Internet]. European Journal of Clinical Pharmacology. 2015 ; 71( 9): 1067-1073.[citado 2024 nov. 07 ] Available from: http://link.springer.com/article/10.1007%2Fs00228-015-1896-x
Trabalho de evento-resumo periodico
MSMB gene variant increases risk of aggressive prostate cancer (2014)
Sanchez, D.; Viana, N.; Saldanha, E.; Oyama, R.; Guimarães, V.; Nesrallah, A.; Passerotti, C.; Srougi, M.; Antunes, A.; Leite, K.; Reis, S.
Unidade: FM
Subjects: DOENÇAS HEREDITÁRIAS, POLIMORFISMO, PROGNÓSTICO, NEOPLASIAS PROSTÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHEZ, D. et al. MSMB gene variant increases risk of aggressive prostate cancer. . Berlim: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2014
APA
Sanchez, D., Viana, N., Saldanha, E., Oyama, R., Guimarães, V., Nesrallah, A., et al. (2014). MSMB gene variant increases risk of aggressive prostate cancer. Berlim: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sanchez D, Viana N, Saldanha E, Oyama R, Guimarães V, Nesrallah A, Passerotti C, Srougi M, Antunes A, Leite K, Reis S. MSMB gene variant increases risk of aggressive prostate cancer. 2014 ; 465 S5.[citado 2024 nov. 07 ]
Vancouver
Sanchez D, Viana N, Saldanha E, Oyama R, Guimarães V, Nesrallah A, Passerotti C, Srougi M, Antunes A, Leite K, Reis S. MSMB gene variant increases risk of aggressive prostate cancer. 2014 ; 465 S5.[citado 2024 nov. 07 ]
Artigo de periodico
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014)
Blitterswijk, Marka van; Mullen, Bianca; Nicholson, Alexandra M.; Bieniek, Kevin F.; Heckman, Michael G.; Baker, Matthew C.; DeJesus‑Hernandez, Mariely; Finch, NiCole A.; Brown, Patricia H.; Murray, Melissa E.; Hsiung, Ging‑Yuek R.; Stewart, Heather; Karydas, Anna M.; Finger, Elizabeth; Kertesz, Andrew; Bigio, Eileen H.; Weintraub, Sandra; Mesulam, Marsel; Hatanpaa, Kimmo J.; White III, Charles L.; Strong, Michael J.; Beach, Thomas G.; Wszolek, Zbigniew K.; Lippa, Carol; Caselli, Richard; Petrucelli, Leonard; Josephs, Keith A.; Parisi, Joseph E.; Knopman, David S.; Petersen, Ronald C.; Mackenzie, Ian R.; Seeley, William W.; Grinberg, Lea T.; Miller, Bruce L.; Boylan, Kevin B.; Graff‑Radford, Neill R.; Boeve, Bradley F.; Dickson, Dennis W.; Rademakers, Rosa
Source: Acta Neuropathologica. Unidade: FM
Subjects: POLIMORFISMO, DOENÇAS NEURODEGENERATIVAS (ETIOLOGIA), MUTAÇÃO GENÉTICA, DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLITTERSWIJK, Marka van et al. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathologica, v. 127, n. 3, p. 397-406, 2014Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00401-013-1240-4. Acesso em: 07 nov. 2024.
APA
Blitterswijk, M. van, Mullen, B., Nicholson, A. M., Bieniek, K. F., Heckman, M. G., Baker, M. C., et al. (2014). TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathologica, 127( 3), 397-406. doi:10.1007/s00401-013-1240-4
NLM
Blitterswijk M van, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus‑Hernandez M, Finch NCA, Brown PH, Murray ME, Hsiung G‑YR, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White III CL, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff‑Radford NR, Boeve BF, Dickson DW, Rademakers R. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia [Internet]. Acta Neuropathologica. 2014 ; 127( 3): 397-406.[citado 2024 nov. 07 ] Available from: http://link.springer.com/article/10.1007/s00401-013-1240-4
Vancouver
Blitterswijk M van, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus‑Hernandez M, Finch NCA, Brown PH, Murray ME, Hsiung G‑YR, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White III CL, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff‑Radford NR, Boeve BF, Dickson DW, Rademakers R. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia [Internet]. Acta Neuropathologica. 2014 ; 127( 3): 397-406.[citado 2024 nov. 07 ] Available from: http://link.springer.com/article/10.1007/s00401-013-1240-4
Trabalho de evento-resumo periodico
ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure (2014)
Bernardez, S.; Santos, P. C. J. L.; Krieger, J. E.; Mansur, A. J.; Pereira, A. C.
Source: European Heart Journal. Conference titles: ESC Congress. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA (ETIOLOGIA), POLIMORFISMO, PROGNÓSTICO, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDEZ, S. et al. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf. Acesso em: 07 nov. 2024. , 2014
APA
Bernardez, S., Santos, P. C. J. L., Krieger, J. E., Mansur, A. J., & Pereira, A. C. (2014). ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf
NLM
Bernardez S, Santos PCJL, Krieger JE, Mansur AJ, Pereira AC. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure [Internet]. European Heart Journal. 2014 ; 35 2.[citado 2024 nov. 07 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf
Vancouver
Bernardez S, Santos PCJL, Krieger JE, Mansur AJ, Pereira AC. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure [Internet]. European Heart Journal. 2014 ; 35 2.[citado 2024 nov. 07 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/35/suppl_1/1.full.pdf
Trabalho de evento-resumo periodico
Clinic Evolution of the Cutaneous Melanoma in Patients with Selected Polymorphism in Nucleotide Excison Repair Genes (2013)
Campagnari, M.; Pedreira Duprat, J.; Chammas, R.; Katsue Furuya, T.; Cirilo, P.; Bertolli, E.
Source: JDDG: Journal der Deutschen Dermatologischen Gesellschaft. Conference titles: World Congress of Melanoma. Unidade: FM
Subjects: MELANOMA, EVOLUÇÃO CLÍNICA, REPARAÇÃO DE DNA, POLIMORFISMO, NUCLEOTÍDEOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPAGNARI, M. et al. Clinic Evolution of the Cutaneous Melanoma in Patients with Selected Polymorphism in Nucleotide Excison Repair Genes. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. Berlin: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/ddg.12161/pdf. Acesso em: 07 nov. 2024. , 2013
APA
Campagnari, M., Pedreira Duprat, J., Chammas, R., Katsue Furuya, T., Cirilo, P., & Bertolli, E. (2013). Clinic Evolution of the Cutaneous Melanoma in Patients with Selected Polymorphism in Nucleotide Excison Repair Genes. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. Berlin: Faculdade de Medicina, Universidade de São Paulo. doi:10.1111/ddg.12161
NLM
Campagnari M, Pedreira Duprat J, Chammas R, Katsue Furuya T, Cirilo P, Bertolli E. Clinic Evolution of the Cutaneous Melanoma in Patients with Selected Polymorphism in Nucleotide Excison Repair Genes [Internet]. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2013 ; 11 48.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/ddg.12161/pdf
Vancouver
Campagnari M, Pedreira Duprat J, Chammas R, Katsue Furuya T, Cirilo P, Bertolli E. Clinic Evolution of the Cutaneous Melanoma in Patients with Selected Polymorphism in Nucleotide Excison Repair Genes [Internet]. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2013 ; 11 48.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/ddg.12161/pdf
Artigo de periodico
CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation (2013)
Santos, Paulo Caleb Junior Lima; Dinardo, Carla Luana; Schettert, Isolmar Tadeu; Soares, Renata Alonso Gadi; Kawabata-Yoshihara, Liz; Benseñor, Isabela Martins; Krieger, José Eduardo; Lotufo, Paulo Andrade; Pereira, Alexandre Costa
Source: European Journal of Clinical Pharmacology. Unidades: FM, HU
Subjects: POLIMORFISMO, ANTICOAGULANTES (FARMACOLOGIA), FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation. European Journal of Clinical Pharmacology, v. 69, n. 4, p. 789-797, 2013Tradução . . Disponível em: https://doi.org/10.1007%2Fs00228-012-1404-5. Acesso em: 07 nov. 2024.
APA
Santos, P. C. J. L., Dinardo, C. L., Schettert, I. T., Soares, R. A. G., Kawabata-Yoshihara, L., Benseñor, I. M., et al. (2013). CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation. European Journal of Clinical Pharmacology, 69( 4), 789-797. doi:10.1007%2Fs00228-012-1404-5
NLM
Santos PCJL, Dinardo CL, Schettert IT, Soares RAG, Kawabata-Yoshihara L, Benseñor IM, Krieger JE, Lotufo PA, Pereira AC. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 4): 789-797.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007%2Fs00228-012-1404-5
Vancouver
Santos PCJL, Dinardo CL, Schettert IT, Soares RAG, Kawabata-Yoshihara L, Benseñor IM, Krieger JE, Lotufo PA, Pereira AC. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 4): 789-797.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007%2Fs00228-012-1404-5
Artigo de periodico
Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss (2012)
Guerra-Shinohara, Elvira Maria ; Bertinato, Juliano Felix; Bueno, Carolina Tosin; Silva, Kelma Cordeiro da; Carvalho, Mario Henrique Burlacchini de; Francisco, Rossana Pulcineli Vieira; Zugaib, Marcelo; Cerda, Alvaro; Morelli, Vânia Maris
Source: Thrombosis and Haemostasis. Unidades: FCF, FM
Subjects: POLIMORFISMO, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss. Thrombosis and Haemostasis, v. 108, n. 4, p. 693-700, 2012Tradução . . Disponível em: https://doi.org/10.1160/TH12-03-0177. Acesso em: 07 nov. 2024.
APA
Guerra-Shinohara, E. M., Bertinato, J. F., Bueno, C. T., Silva, K. C. da, Carvalho, M. H. B. de, Francisco, R. P. V., et al. (2012). Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss. Thrombosis and Haemostasis, 108( 4), 693-700. doi:10.1160/TH12-03-0177
NLM
Guerra-Shinohara EM, Bertinato JF, Bueno CT, Silva KC da, Carvalho MHB de, Francisco RPV, Zugaib M, Cerda A, Morelli VM. Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss [Internet]. Thrombosis and Haemostasis. 2012 ;108( 4): 693-700.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1160/TH12-03-0177
Vancouver
Guerra-Shinohara EM, Bertinato JF, Bueno CT, Silva KC da, Carvalho MHB de, Francisco RPV, Zugaib M, Cerda A, Morelli VM. Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss [Internet]. Thrombosis and Haemostasis. 2012 ;108( 4): 693-700.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1160/TH12-03-0177
Artigo de periodico
Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis (2012)
Wojitani, Maria Dulce Kaoro Horie; Aguiar, Lana Maria de; Baracat, Edmund Chada; Linhares, Iara Moreno
Source: Archives of Gynecology and Obstetrics. Unidade: FM
Subjects: LECTINAS (ANTAGONISTAS E INIBIDORES), INTERLEUCINAS, DOENÇAS VAGINAIS (MICROBIOLOGIA;GENÉTICA), POLIMORFISMO, CANDIDÍASE, RECIDIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WOJITANI, Maria Dulce Kaoro Horie et al. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis. Archives of Gynecology and Obstetrics, v. 285, n. 1, p. 149-153, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00404-011-1920-z. Acesso em: 07 nov. 2024.
APA
Wojitani, M. D. K. H., Aguiar, L. M. de, Baracat, E. C., & Linhares, I. M. (2012). Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis. Archives of Gynecology and Obstetrics, 285( 1), 149-153. doi:10.1007/s00404-011-1920-z
NLM
Wojitani MDKH, Aguiar LM de, Baracat EC, Linhares IM. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis [Internet]. Archives of Gynecology and Obstetrics. 2012 ; 285( 1): 149-153.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00404-011-1920-z
Vancouver
Wojitani MDKH, Aguiar LM de, Baracat EC, Linhares IM. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis [Internet]. Archives of Gynecology and Obstetrics. 2012 ; 285( 1): 149-153.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00404-011-1920-z
Artigo de periodico
Association Between Genetics of Diabetes, Coronary Artery Disease, and Macrovascular Complications: Exploring a Common Ground Hypothesis (2011)
Sousa, André G; Selvatici, Lívia; Krieger, José Eduardo; Pereira, Alexandre C
Source: The rewiew of diabetic studies. Unidade: FM
Subjects: DIABETES MELLITUS (GENÉTICA), CORONARIOPATIA (COMPLICAÇÕES), DOENÇAS VASCULARES, POLIMORFISMO, GENOMAS, HIPERGLICEMIA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, André G et al. Association Between Genetics of Diabetes, Coronary Artery Disease, and Macrovascular Complications: Exploring a Common Ground Hypothesis. The rewiew of diabetic studies, v. 8, n. 2, p. 230-244, 2011Tradução . . Disponível em: https://doi.org/10.1900/RDS.2011.8.230. Acesso em: 07 nov. 2024.
APA
Sousa, A. G., Selvatici, L., Krieger, J. E., & Pereira, A. C. (2011). Association Between Genetics of Diabetes, Coronary Artery Disease, and Macrovascular Complications: Exploring a Common Ground Hypothesis. The rewiew of diabetic studies, 8( 2), 230-244. doi:10.1900/RDS.2011.8.230
NLM
Sousa AG, Selvatici L, Krieger JE, Pereira AC. Association Between Genetics of Diabetes, Coronary Artery Disease, and Macrovascular Complications: Exploring a Common Ground Hypothesis [Internet]. The rewiew of diabetic studies. 2011 ; 8( 2): 230-244.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1900/RDS.2011.8.230
Vancouver
Sousa AG, Selvatici L, Krieger JE, Pereira AC. Association Between Genetics of Diabetes, Coronary Artery Disease, and Macrovascular Complications: Exploring a Common Ground Hypothesis [Internet]. The rewiew of diabetic studies. 2011 ; 8( 2): 230-244.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1900/RDS.2011.8.230
Artigo de periodico
Association between BanI genotype and increased phospholipase A2 activity in schizophrenia (2007)
Barbosa, Nadia R.; Junqueira, Ricardo M.; Vallada Filho, Homero P.; Gattaz, Wagner Farid
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: GENÓTIPOS, FOSFOLIPASES A, POLIMORFISMO, ESQUIZOFRENIA (ATIVIDADE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Nadia R. et al. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, v. 257, p. 340-343, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00406-007-0736-0. Acesso em: 07 nov. 2024.
APA
Barbosa, N. R., Junqueira, R. M., Vallada Filho, H. P., & Gattaz, W. F. (2007). Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 257, 340-343. doi:10.1007/s00406-007-0736-0
NLM
Barbosa NR, Junqueira RM, Vallada Filho HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 340-343.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-007-0736-0
Vancouver
Barbosa NR, Junqueira RM, Vallada Filho HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 340-343.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-007-0736-0
Artigo de periodico
Fc(gamma)RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patientf (2004)
Bazilio, Ana Paula; Viana, Vilma dos Santos Trindade; Barros, Rui Toledo; Woronik, Viktória; Bonfá, Eloísa Silva Dutra de Oliveira; Monteiro, Renato C.
Source: Nephrology Dialysis Transplantation. Unidade: FM
Subjects: LÚPUS ERITEMATOSO CUTÂNEO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAZILIO, Ana Paula et al. Fc(gamma)RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patientf. Nephrology Dialysis Transplantation, v. 19, n. 6, p. 1427-1431, 2004Tradução . . Disponível em: https://doi.org/10.1093/ndt/gfh121. Acesso em: 07 nov. 2024.
APA
Bazilio, A. P., Viana, V. dos S. T., Barros, R. T., Woronik, V., Bonfá, E. S. D. de O., & Monteiro, R. C. (2004). Fc(gamma)RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patientf. Nephrology Dialysis Transplantation, 19( 6), 1427-1431. doi:10.1093/ndt/gfh121
NLM
Bazilio AP, Viana V dos ST, Barros RT, Woronik V, Bonfá ESD de O, Monteiro RC. Fc(gamma)RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patientf [Internet]. Nephrology Dialysis Transplantation. 2004 ; 19( 6): 1427-1431.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/ndt/gfh121
Vancouver
Bazilio AP, Viana V dos ST, Barros RT, Woronik V, Bonfá ESD de O, Monteiro RC. Fc(gamma)RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patientf [Internet]. Nephrology Dialysis Transplantation. 2004 ; 19( 6): 1427-1431.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/ndt/gfh121
Artigo de periodico
Association of a new polymorphism in ALOX12 gene with bipolar disorder (2003)
Fridman, Cintia; Ojopi, Élida P. B.; Gregório, Sheila P.; Ikenaga, Elisa H.; Moreno, Doris H.; Demetrio, Frederico N.; Guimarães, Pedro E. M.; Vallada, Homero P.; Gattaz, Wagner Farid; Dias Neto, Emmanuel
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, POLIMORFISMO, LÍTIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRIDMAN, Cintia et al. Association of a new polymorphism in ALOX12 gene with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience, v. 253, p. 40-43, 2003Tradução . . Disponível em: https://doi.org/10.1007/s00406-003-0404-y. Acesso em: 07 nov. 2024.
APA
Fridman, C., Ojopi, É. P. B., Gregório, S. P., Ikenaga, E. H., Moreno, D. H., Demetrio, F. N., et al. (2003). Association of a new polymorphism in ALOX12 gene with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience, 253, 40-43. doi:10.1007/s00406-003-0404-y
NLM
Fridman C, Ojopi ÉPB, Gregório SP, Ikenaga EH, Moreno DH, Demetrio FN, Guimarães PEM, Vallada HP, Gattaz WF, Dias Neto E. Association of a new polymorphism in ALOX12 gene with bipolar disorder [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2003 ; 253 40-43.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-003-0404-y
Vancouver
Fridman C, Ojopi ÉPB, Gregório SP, Ikenaga EH, Moreno DH, Demetrio FN, Guimarães PEM, Vallada HP, Gattaz WF, Dias Neto E. Association of a new polymorphism in ALOX12 gene with bipolar disorder [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2003 ; 253 40-43.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-003-0404-y

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em